Is the product compliant with safety regulations?

Yes, it is certified by FDA 21 CFR 175.300 and is APE-free and REACH Annex XVII compliant.

What are the main applications of this surfactant?

It is used in solvent gravure inks, HT epoxy adhesives, metal degreasers, and ceramic glaze additives.

Evo-nik Surfynol 104S Synergized Active Surfactant Liquid Zero-Foaming Wetting Agent for Solvent Inks & HT Adhesives

Name: Evo-nik Surfynol 104S Synergized Active Surfactant Liquid Zero-Foaming Wetting Agent for Solvent Inks & HT Adhesives
Brand: Guangzhou Eric Wei Chemical Co., Ltd.
SKU: 2126782732

Guangdong, ChinaGuangzhou Eric Wei Chemical Co., Ltd.

US$14.50

25-999 kilogram

US$12.50

1,000+ kilogram

Product profile

Customization

Available

CAS No.

68515-73-1

Appearance

Liquid

Model NO.

Surfynol 104S

Usage

Plastic Auxiliary Agents, Coating Auxiliary Agents

Color

transparent

Other Names

Wetting Agent

Type

50%Surfynol104+ 50%2- Butoxyethanol

EINECS No.

200-0000-00-0

Selling Units

Single item

Classification

Chemical auxiliary agent

Purity

99%

Model

Surfynol 104S

Transport Package

Barrel

Specification

25 KGS

Trademark

Evo-nik

Origin

Germany

Key features

FDA & REACH Compliant: Certified by FDA 21 CFR 175.300 and compliant with REACH Annex XVII.

OEM & ODM Services: Offers full customization from designs with available R&D support.

High Printing Efficiency: Increases solvent gravure ink printing speed by +30% on OPP films.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryFull Customization

Guangzhou Eric Wei Chemical Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Designs, Full Customization CertifiedExport Year: 1 Year CertifiedNearest Port: Guangzhou PortAverage Response Time: ≤1.71h

AI-Powered supplier vetting

SummaryThe supplier is identified as a trading company and limited company offering polymers, catalysts, chemical additives, pigments, dyes, and other chemical raw materials. It reports ODM and OEM capabilities, full customization from customer designs, and one R&D engineer, with new products launched during the past year. However, quality-control traceability and assurance status are unknown, testing equipment is reported as zero, and complaint handling lacks written procedures or records. The supplier has no stated inventory, overseas warehouse, overseas showroom, or overseas agent/branch capability. Financial information is presented only as years of available records, without sufficient evidence to assess financial strength. Service-management controls are weak or undocumented, although off-season lead time is within 15 working days and 50 qualified service suppliers are reported.

After-Sales capabilityThe supplier reports no inventory, overseas warehouse, overseas showroom, or overseas agent/branch capability. Customer complaint handling has no written procedures or records, while service-capability assessment and corrective-action procedures are also undocumented, indicating insufficient evidence of a structured after-sales system.

R&D capabilityThe supplier reports one R&D engineer, new products launched during the past year, and ODM services. The engineer’s stated responsibility is sample design, but there is no available SDK, so the evidence supports some product-development activity but not broad or advanced innovation capability.

Production capacityThe supplier is identified as a trading company, and the provided materials do not confirm owned production facilities or manufacturing capacity. It reports no inventory capability and zero quality-control testing equipment, leaving production capability unsupported and quality-control infrastructure particularly limited.

Customization capabilityThe supplier explicitly offers customization from customer designs and full customization, as well as ODM services. One R&D engineer is assigned to sample design, providing direct evidence of customization support, although the limited R&D staffing may constrain capacity.